Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Transplantation Proceedings|June 18, 2013
Mouse T cells engineered to display on their surface a novel form of FasL protein undergo apoptosis when stimulated with alloantigens: implications for graft-versus-host diseaseE S Yolcu, N P SinghTransplantation Proceedings|June 18, 2013
Immunomodulation with SA-FasL protein as an effective means of preventing islet allograft rejection in chemically diabetic NOD miceE S Yolcu, H Zhao, H ShirwanCancer Gene Therapy|June 19, 2010
Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapyR K Sharma, E S Yolcu, K G Elpek, et al.Transplantation Proceedings|June 18, 2013
Posttransplantation systemic immunomodulation with SA-FasL-engineered donor splenocytes has robust efficacy in preventing cardiac allograft rejection in miceH Zhao, K B Woodward, H Shirwan, et al.Transplantation Proceedings|November 22, 2011
Engineering of bone marrow cells with fas-ligand protein-enhances donor-specific tolerance to solid organsE M Askenasy, Y Shushlav, Z Sun, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2015
Characterization of Human CD8(+)TCR(-) Facilitating Cells In Vitro and In Vivo in a NOD/SCID/IL2rγ(null) Mouse ModelY Huang, M J Elliott, E S Yolcu, et al.Pageof 1